Asuragen and Illumina will join forces to develop and commercialise genomics-based companion diagnostics. The partnership will utilise NGS's Quantidex Asurgen product platform in conjunction with Illumina's MiSeqDx instrument.
Asuragen and Illumina will join forces to develop and commercialise genomics-based companion diagnostics. The partnership will utilise Asurgen's Quantidex NGS product platform in conjunction with Illumina's MiSeqDx instrument.